Literature DB >> 22198445

Increased risk of antipsychotic-related QT prolongation during nighttime: a 24-hour holter electrocardiogram recording study.

Junzo Watanabe1, Yutaro Suzuki, Naoki Fukui, Shin Ono, Takuro Sugai, Nobuto Tsuneyama, Toshiyuki Someya.   

Abstract

Most antipsychotic agents can cause QT prolongation, which causes torsades de pointes. The QT interval in healthy subjects is longer during nighttime than during daytime. The QT interval of patients treated with antipsychotics may be prolonged during nighttime, and the effects of antipsychotics on the QT interval may differ between antipsychotics. This study investigated the circadian dynamics of the QT interval in patients treated with antipsychotics and healthy controls, using a 24-hour Holter electrocardiogram in a clinical setting. Sixty-six patients with a diagnosis of schizophrenia that were treated with risperidone or olanzapine and 40 healthy volunteers were enrolled. The QT intervals were corrected using the Fridericia formula (QTcF = QT / RR). Mean ± SD nighttime QTcFs were 411.6 ± 29.0, 395.9 ± 21.2, and 387.8 ± 19.0 milliseconds (ms) in the risperidone, olanzapine, and control groups, respectively. The mean daytime QTcFs were 397.7 ± 23.4, 392.4 ± 18.9, and 382.6 ± 17.3 ms, respectively. The mean nighttime QTcF of the risperidone group was significantly longer than that of the olanzapine and control groups, although there was no significant difference in the mean daytime QTcF between the risperidone and olanzapine groups. The current study used 24-hour Holter electrocardiograms to reveal significantly longer QT intervals in the risperidone group especially during nighttime. In clinical practices, evaluations of the QT interval have been conducted over short periods in the daytime, but it is believed that such methods may not be able to fully elucidate the effects of antipsychotics on the QT interval.

Entities:  

Mesh:

Substances:

Year:  2012        PMID: 22198445     DOI: 10.1097/JCP.0b013e31823f6f21

Source DB:  PubMed          Journal:  J Clin Psychopharmacol        ISSN: 0271-0749            Impact factor:   3.153


  9 in total

1.  Mandatory electrocardiographic monitoring in young patients treated with psychoactive drugs.

Authors:  Renata Rizzo; Mariangela Gulisano; Paola V Calì; Alfredo Di Pino
Journal:  Eur Child Adolesc Psychiatry       Date:  2013-04-04       Impact factor: 4.785

Review 2.  QTc interval prolongation and torsade de pointes associated with second-generation antipsychotics and antidepressants: a comprehensive review.

Authors:  Mehrul Hasnain; W Victor R Vieweg
Journal:  CNS Drugs       Date:  2014-10       Impact factor: 5.749

3.  Short-term effects of oral dronedarone administration on cardiac function, blood pressure and electrocardiogram in conscious telemetry dogs.

Authors:  Nakkawee Saengklub; Brad Youngblood; Carlos Del Rio; Suwanakiet Sawangkoon; Robert L Hamlin; Anusak Kijtawornrat
Journal:  J Vet Med Sci       Date:  2016-02-26       Impact factor: 1.267

4.  Levofloxacin-Induced QTc Prolongation Depends on the Time of Drug Administration.

Authors:  L Kervezee; V Gotta; J Stevens; W Birkhoff; Imc Kamerling; M Danhof; J H Meijer; J Burggraaf
Journal:  CPT Pharmacometrics Syst Pharmacol       Date:  2016-08-01

5.  Response to "Time of the Day and Magnitude of the Effect of a Drug on the QTc Interval".

Authors:  L Kervezee; J Burggraaf
Journal:  CPT Pharmacometrics Syst Pharmacol       Date:  2017-05

6.  Effects of Antipsychotics on Arrhythmogenic Parameters in Schizophrenia Patients: Beyond Corrected QT Interval.

Authors:  Hiroaki Okayasu; Takahiro Shinozaki; Yumiko Takano; Norio Sugawara; Kumiko Fujii; Norio Yasui-Furukori; Yuji Ozeki; Kazutaka Shimoda
Journal:  Neuropsychiatr Dis Treat       Date:  2021-01-27       Impact factor: 2.570

Review 7.  QTc Interval Prolongation with Therapies Used to Treat Patients with Parkinson's Disease Psychosis: A Narrative Review.

Authors:  Yasar Torres-Yaghi; Amelia Carwin; Jacob Carolan; Steven Nakano; Fahd Amjad; Fernando Pagan
Journal:  Neuropsychiatr Dis Treat       Date:  2021-12-24       Impact factor: 2.570

Review 8.  Chronopharmacology: new insights and therapeutic implications.

Authors:  Robert Dallmann; Steven A Brown; Frédéric Gachon
Journal:  Annu Rev Pharmacol Toxicol       Date:  2013-10-16       Impact factor: 13.820

9.  Diurnal variation in P-glycoprotein-mediated transport and cerebrospinal fluid turnover in the brain.

Authors:  Laura Kervezee; Robin Hartman; Dirk-Jan van den Berg; Shinji Shimizu; Yumi Emoto-Yamamoto; Johanna H Meijer; Elizabeth C M de Lange
Journal:  AAPS J       Date:  2014-06-11       Impact factor: 4.009

  9 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.